nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCB1—peripheral nervous system neoplasm	0.294	1	CbGaD
Dipyridamole—ABCC5—Cisplatin—peripheral nervous system neoplasm	0.126	0.506	CbGbCtD
Dipyridamole—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0295	0.118	CbGbCtD
Dipyridamole—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0295	0.118	CbGbCtD
Dipyridamole—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0205	0.082	CbGbCtD
Dipyridamole—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0126	0.0505	CbGbCtD
Dipyridamole—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0117	0.0471	CbGbCtD
Dipyridamole—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0115	0.0463	CbGbCtD
Dipyridamole—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00787	0.0316	CbGbCtD
Dipyridamole—PDE8B—forelimb—peripheral nervous system neoplasm	0.00658	0.175	CbGeAlD
Dipyridamole—PDE10A—ganglion—peripheral nervous system neoplasm	0.00373	0.099	CbGeAlD
Dipyridamole—PDE2A—tongue—peripheral nervous system neoplasm	0.00369	0.0979	CbGeAlD
Dipyridamole—PDE8B—ganglion—peripheral nervous system neoplasm	0.00356	0.0944	CbGeAlD
Dipyridamole—PRUNE—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.0024	0.372	CbGdCrCtD
Dipyridamole—PRUNE—Podofilox—Etoposide—peripheral nervous system neoplasm	0.0024	0.372	CbGdCrCtD
Dipyridamole—PDE2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00183	0.0486	CbGeAlD
Dipyridamole—PRUNE—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00165	0.256	CbGdCrCtD
Dipyridamole—PDE8A—trigeminal ganglion—peripheral nervous system neoplasm	0.00157	0.0417	CbGeAlD
Dipyridamole—PDE1C—cerebellum—peripheral nervous system neoplasm	0.00154	0.0409	CbGeAlD
Dipyridamole—PRUNE—cerebellum—peripheral nervous system neoplasm	0.00139	0.0369	CbGeAlD
Dipyridamole—PDE1A—brainstem—peripheral nervous system neoplasm	0.00135	0.0357	CbGeAlD
Dipyridamole—PDE6D—cerebellum—peripheral nervous system neoplasm	0.00134	0.0357	CbGeAlD
Dipyridamole—PDE6B—cerebellum—peripheral nervous system neoplasm	0.00132	0.0351	CbGeAlD
Dipyridamole—ABCC5—trigeminal ganglion—peripheral nervous system neoplasm	0.00098	0.026	CbGeAlD
Dipyridamole—SLC29A1—trigeminal ganglion—peripheral nervous system neoplasm	0.0009	0.0239	CbGeAlD
Dipyridamole—PDE10A—cerebellum—peripheral nervous system neoplasm	0.000799	0.0212	CbGeAlD
Dipyridamole—PDE2A—cerebellum—peripheral nervous system neoplasm	0.000799	0.0212	CbGeAlD
Dipyridamole—PDE1B—cerebellum—peripheral nervous system neoplasm	0.000792	0.021	CbGeAlD
Dipyridamole—PDE8B—cerebellum—peripheral nervous system neoplasm	0.000762	0.0202	CbGeAlD
Dipyridamole—PDE3B—cerebellum—peripheral nervous system neoplasm	0.000745	0.0198	CbGeAlD
Dipyridamole—PDE8A—cerebellum—peripheral nervous system neoplasm	0.000686	0.0182	CbGeAlD
Dipyridamole—PDE1A—cerebellum—peripheral nervous system neoplasm	0.000664	0.0176	CbGeAlD
Dipyridamole—PDE4A—cerebellum—peripheral nervous system neoplasm	0.00055	0.0146	CbGeAlD
Dipyridamole—PDE5A—cerebellum—peripheral nervous system neoplasm	0.000468	0.0124	CbGeAlD
Dipyridamole—PDE3A—cerebellum—peripheral nervous system neoplasm	0.000455	0.0121	CbGeAlD
Dipyridamole—ABCC5—cerebellum—peripheral nervous system neoplasm	0.000428	0.0114	CbGeAlD
Dipyridamole—SLC29A1—cerebellum—peripheral nervous system neoplasm	0.000393	0.0104	CbGeAlD
Dipyridamole—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000237	0.00628	CbGeAlD
Dipyridamole—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000842	CcSEcCtD
Dipyridamole—Cough—Etoposide—peripheral nervous system neoplasm	0.000214	0.000841	CcSEcCtD
Dipyridamole—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000841	CcSEcCtD
Dipyridamole—Headache—Topotecan—peripheral nervous system neoplasm	0.000214	0.00084	CcSEcCtD
Dipyridamole—Rash—Tretinoin—peripheral nervous system neoplasm	0.000214	0.000839	CcSEcCtD
Dipyridamole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.000839	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000214	0.000839	CcSEcCtD
Dipyridamole—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000838	CcSEcCtD
Dipyridamole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000214	0.000838	CcSEcCtD
Dipyridamole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.000838	CcSEcCtD
Dipyridamole—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000213	0.000837	CcSEcCtD
Dipyridamole—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000213	0.000835	CcSEcCtD
Dipyridamole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000213	0.000835	CcSEcCtD
Dipyridamole—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000834	CcSEcCtD
Dipyridamole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000212	0.000833	CcSEcCtD
Dipyridamole—Headache—Tretinoin—peripheral nervous system neoplasm	0.000212	0.000833	CcSEcCtD
Dipyridamole—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000212	0.000832	CcSEcCtD
Dipyridamole—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.000831	CcSEcCtD
Dipyridamole—Pain—Vincristine—peripheral nervous system neoplasm	0.000212	0.000831	CcSEcCtD
Dipyridamole—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.00083	CcSEcCtD
Dipyridamole—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000212	0.00083	CcSEcCtD
Dipyridamole—Rash—Melphalan—peripheral nervous system neoplasm	0.000211	0.000828	CcSEcCtD
Dipyridamole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000211	0.000827	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000824	CcSEcCtD
Dipyridamole—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.000821	CcSEcCtD
Dipyridamole—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00082	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00082	CcSEcCtD
Dipyridamole—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000817	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000208	0.000815	CcSEcCtD
Dipyridamole—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000207	0.000811	CcSEcCtD
Dipyridamole—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000205	0.000803	CcSEcCtD
Dipyridamole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.000801	CcSEcCtD
Dipyridamole—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.000801	CcSEcCtD
Dipyridamole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000797	CcSEcCtD
Dipyridamole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000203	0.000796	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000202	0.000794	CcSEcCtD
Dipyridamole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000201	0.00079	CcSEcCtD
Dipyridamole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000201	0.00079	CcSEcCtD
Dipyridamole—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00079	CcSEcCtD
Dipyridamole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000201	0.000787	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000199	0.000782	CcSEcCtD
Dipyridamole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.00078	CcSEcCtD
Dipyridamole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000199	0.00078	CcSEcCtD
Dipyridamole—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000776	CcSEcCtD
Dipyridamole—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000771	CcSEcCtD
Dipyridamole—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000196	0.00077	CcSEcCtD
Dipyridamole—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000196	0.000768	CcSEcCtD
Dipyridamole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000196	0.000768	CcSEcCtD
Dipyridamole—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000766	CcSEcCtD
Dipyridamole—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000195	0.000764	CcSEcCtD
Dipyridamole—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000194	0.000761	CcSEcCtD
Dipyridamole—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000758	CcSEcCtD
Dipyridamole—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000758	CcSEcCtD
Dipyridamole—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000756	CcSEcCtD
Dipyridamole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00019	0.000744	CcSEcCtD
Dipyridamole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000743	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000189	0.000741	CcSEcCtD
Dipyridamole—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000187	0.000735	CcSEcCtD
Dipyridamole—Pain—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000734	CcSEcCtD
Dipyridamole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000723	CcSEcCtD
Dipyridamole—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000718	CcSEcCtD
Dipyridamole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000182	0.000716	CcSEcCtD
Dipyridamole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000713	CcSEcCtD
Dipyridamole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00018	0.000708	CcSEcCtD
Dipyridamole—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00018	0.000707	CcSEcCtD
Dipyridamole—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000179	0.000701	CcSEcCtD
Dipyridamole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000178	0.000699	CcSEcCtD
Dipyridamole—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000699	CcSEcCtD
Dipyridamole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000178	0.000697	CcSEcCtD
Dipyridamole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000176	0.000691	CcSEcCtD
Dipyridamole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000176	0.00069	CcSEcCtD
Dipyridamole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.000685	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000173	0.000679	CcSEcCtD
Dipyridamole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000173	0.000678	CcSEcCtD
Dipyridamole—Pain—Etoposide—peripheral nervous system neoplasm	0.000172	0.000673	CcSEcCtD
Dipyridamole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000667	CcSEcCtD
Dipyridamole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000169	0.000665	CcSEcCtD
Dipyridamole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000165	0.000648	CcSEcCtD
Dipyridamole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.000646	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000164	0.000643	CcSEcCtD
Dipyridamole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000164	0.000642	CcSEcCtD
Dipyridamole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000163	0.000641	CcSEcCtD
Dipyridamole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000636	CcSEcCtD
Dipyridamole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000635	CcSEcCtD
Dipyridamole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000633	CcSEcCtD
Dipyridamole—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000632	CcSEcCtD
Dipyridamole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000631	CcSEcCtD
Dipyridamole—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000159	0.000625	CcSEcCtD
Dipyridamole—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000624	CcSEcCtD
Dipyridamole—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000622	CcSEcCtD
Dipyridamole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000159	0.000622	CcSEcCtD
Dipyridamole—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000621	CcSEcCtD
Dipyridamole—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000621	CcSEcCtD
Dipyridamole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000618	CcSEcCtD
Dipyridamole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000157	0.000618	CcSEcCtD
Dipyridamole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000616	CcSEcCtD
Dipyridamole—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000616	CcSEcCtD
Dipyridamole—Rash—Vincristine—peripheral nervous system neoplasm	0.000156	0.000612	CcSEcCtD
Dipyridamole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000156	0.000612	CcSEcCtD
Dipyridamole—Headache—Vincristine—peripheral nervous system neoplasm	0.000155	0.000608	CcSEcCtD
Dipyridamole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000599	CcSEcCtD
Dipyridamole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000588	CcSEcCtD
Dipyridamole—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000585	CcSEcCtD
Dipyridamole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000148	0.00058	CcSEcCtD
Dipyridamole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000579	CcSEcCtD
Dipyridamole—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000577	CcSEcCtD
Dipyridamole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000147	0.000577	CcSEcCtD
Dipyridamole—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000576	CcSEcCtD
Dipyridamole—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000576	CcSEcCtD
Dipyridamole—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000576	CcSEcCtD
Dipyridamole—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000574	CcSEcCtD
Dipyridamole—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000574	CcSEcCtD
Dipyridamole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000572	CcSEcCtD
Dipyridamole—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00057	CcSEcCtD
Dipyridamole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000144	0.000565	CcSEcCtD
Dipyridamole—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000563	CcSEcCtD
Dipyridamole—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000561	CcSEcCtD
Dipyridamole—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.00056	CcSEcCtD
Dipyridamole—Chills—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000557	CcSEcCtD
Dipyridamole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000142	0.000557	CcSEcCtD
Dipyridamole—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000555	CcSEcCtD
Dipyridamole—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000549	CcSEcCtD
Dipyridamole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000139	0.000546	CcSEcCtD
Dipyridamole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000542	CcSEcCtD
Dipyridamole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000541	CcSEcCtD
Dipyridamole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000137	0.000538	CcSEcCtD
Dipyridamole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000536	CcSEcCtD
Dipyridamole—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000533	CcSEcCtD
Dipyridamole—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000533	CcSEcCtD
Dipyridamole—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000533	CcSEcCtD
Dipyridamole—Tension—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00053	CcSEcCtD
Dipyridamole—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000529	CcSEcCtD
Dipyridamole—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000525	CcSEcCtD
Dipyridamole—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000523	CcSEcCtD
Dipyridamole—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000521	CcSEcCtD
Dipyridamole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000133	0.00052	CcSEcCtD
Dipyridamole—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00052	CcSEcCtD
Dipyridamole—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000519	CcSEcCtD
Dipyridamole—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000518	CcSEcCtD
Dipyridamole—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000515	CcSEcCtD
Dipyridamole—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000513	CcSEcCtD
Dipyridamole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00013	0.00051	CcSEcCtD
Dipyridamole—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000508	CcSEcCtD
Dipyridamole—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000501	CcSEcCtD
Dipyridamole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000128	0.0005	CcSEcCtD
Dipyridamole—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000499	CcSEcCtD
Dipyridamole—Rash—Etoposide—peripheral nervous system neoplasm	0.000126	0.000496	CcSEcCtD
Dipyridamole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000126	0.000496	CcSEcCtD
Dipyridamole—Headache—Etoposide—peripheral nervous system neoplasm	0.000126	0.000493	CcSEcCtD
Dipyridamole—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000493	CcSEcCtD
Dipyridamole—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000491	CcSEcCtD
Dipyridamole—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00049	CcSEcCtD
Dipyridamole—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000487	CcSEcCtD
Dipyridamole—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000486	CcSEcCtD
Dipyridamole—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000486	CcSEcCtD
Dipyridamole—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000485	CcSEcCtD
Dipyridamole—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000484	CcSEcCtD
Dipyridamole—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000481	CcSEcCtD
Dipyridamole—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000478	CcSEcCtD
Dipyridamole—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000475	CcSEcCtD
Dipyridamole—Cough—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000472	CcSEcCtD
Dipyridamole—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000468	CcSEcCtD
Dipyridamole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000119	0.000467	CcSEcCtD
Dipyridamole—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000467	CcSEcCtD
Dipyridamole—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000464	CcSEcCtD
Dipyridamole—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000462	CcSEcCtD
Dipyridamole—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00046	CcSEcCtD
Dipyridamole—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00046	CcSEcCtD
Dipyridamole—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00046	CcSEcCtD
Dipyridamole—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000459	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000457	CcSEcCtD
Dipyridamole—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000455	CcSEcCtD
Dipyridamole—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000451	CcSEcCtD
Dipyridamole—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000115	0.00045	CcSEcCtD
Dipyridamole—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000449	CcSEcCtD
Dipyridamole—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000448	CcSEcCtD
Dipyridamole—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000442	CcSEcCtD
Dipyridamole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000441	CcSEcCtD
Dipyridamole—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000441	CcSEcCtD
Dipyridamole—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000439	CcSEcCtD
Dipyridamole—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000436	CcSEcCtD
Dipyridamole—Shock—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000434	CcSEcCtD
Dipyridamole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000433	CcSEcCtD
Dipyridamole—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000433	CcSEcCtD
Dipyridamole—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000432	CcSEcCtD
Dipyridamole—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000432	CcSEcCtD
Dipyridamole—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00043	CcSEcCtD
Dipyridamole—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000428	CcSEcCtD
Dipyridamole—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000426	CcSEcCtD
Dipyridamole—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000426	CcSEcCtD
Dipyridamole—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000426	CcSEcCtD
Dipyridamole—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000426	CcSEcCtD
Dipyridamole—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000424	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000423	CcSEcCtD
Dipyridamole—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000421	CcSEcCtD
Dipyridamole—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000416	CcSEcCtD
Dipyridamole—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000412	CcSEcCtD
Dipyridamole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000408	CcSEcCtD
Dipyridamole—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000408	CcSEcCtD
Dipyridamole—ABCB1—cerebellum—peripheral nervous system neoplasm	0.000103	0.00274	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000402	CcSEcCtD
Dipyridamole—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000402	CcSEcCtD
Dipyridamole—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.0004	CcSEcCtD
Dipyridamole—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.0004	CcSEcCtD
Dipyridamole—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000398	CcSEcCtD
Dipyridamole—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000396	CcSEcCtD
Dipyridamole—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000396	CcSEcCtD
Dipyridamole—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000395	CcSEcCtD
Dipyridamole—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000393	CcSEcCtD
Dipyridamole—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000392	CcSEcCtD
Dipyridamole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.9e-05	0.000388	CcSEcCtD
Dipyridamole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000381	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000381	CcSEcCtD
Dipyridamole—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.00038	CcSEcCtD
Dipyridamole—Pain—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000377	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000372	CcSEcCtD
Dipyridamole—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000366	CcSEcCtD
Dipyridamole—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000364	CcSEcCtD
Dipyridamole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000363	CcSEcCtD
Dipyridamole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000363	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000361	CcSEcCtD
Dipyridamole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.16e-05	0.000359	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000352	CcSEcCtD
Dipyridamole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000352	CcSEcCtD
Dipyridamole—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.00035	CcSEcCtD
Dipyridamole—Pain—Doxorubicin—peripheral nervous system neoplasm	8.9e-05	0.000349	CcSEcCtD
Dipyridamole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.000349	CcSEcCtD
Dipyridamole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000336	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000334	CcSEcCtD
Dipyridamole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000325	CcSEcCtD
Dipyridamole—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000324	CcSEcCtD
Dipyridamole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.22e-05	0.000323	CcSEcCtD
Dipyridamole—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000316	CcSEcCtD
Dipyridamole—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000312	CcSEcCtD
Dipyridamole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000302	CcSEcCtD
Dipyridamole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000301	CcSEcCtD
Dipyridamole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000293	CcSEcCtD
Dipyridamole—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000292	CcSEcCtD
Dipyridamole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000289	CcSEcCtD
Dipyridamole—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.00028	CcSEcCtD
Dipyridamole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000279	CcSEcCtD
Dipyridamole—Rash—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000278	CcSEcCtD
Dipyridamole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.08e-05	0.000278	CcSEcCtD
Dipyridamole—Headache—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000276	CcSEcCtD
Dipyridamole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.00027	CcSEcCtD
Dipyridamole—Nausea—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000262	CcSEcCtD
Dipyridamole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000259	CcSEcCtD
Dipyridamole—Rash—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000257	CcSEcCtD
Dipyridamole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.55e-05	0.000257	CcSEcCtD
Dipyridamole—Headache—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000256	CcSEcCtD
Dipyridamole—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000242	CcSEcCtD
Dipyridamole—PDE8A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.69e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.69e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.68e-05	0.000233	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—NRAS—peripheral nervous system neoplasm	3.67e-05	0.000232	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.63e-05	0.00023	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.63e-05	0.00023	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.63e-05	0.000229	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.62e-05	0.000229	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GNAS—peripheral nervous system neoplasm	3.62e-05	0.000229	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.61e-05	0.000228	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.59e-05	0.000227	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.56e-05	0.000225	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.55e-05	0.000225	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.53e-05	0.000224	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.51e-05	0.000222	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.5e-05	0.000222	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—AKT1—peripheral nervous system neoplasm	3.48e-05	0.00022	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.46e-05	0.000219	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—NRAS—peripheral nervous system neoplasm	3.41e-05	0.000216	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.41e-05	0.000216	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—NRAS—peripheral nervous system neoplasm	3.39e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.39e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.39e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000214	CbGpPWpGaD
Dipyridamole—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000214	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.37e-05	0.000213	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.37e-05	0.000213	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—NRAS—peripheral nervous system neoplasm	3.36e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—AKT1—peripheral nervous system neoplasm	3.35e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—AKT1—peripheral nervous system neoplasm	3.35e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—NRAS—peripheral nervous system neoplasm	3.34e-05	0.000212	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—peripheral nervous system neoplasm	3.33e-05	0.000211	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.32e-05	0.00021	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.31e-05	0.000209	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.3e-05	0.000209	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.29e-05	0.000208	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.26e-05	0.000206	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—PTPN11—peripheral nervous system neoplasm	3.25e-05	0.000206	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.24e-05	0.000205	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.22e-05	0.000204	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—HRAS—peripheral nervous system neoplasm	3.19e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.17e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.17e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.17e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MYC—peripheral nervous system neoplasm	3.16e-05	0.0002	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.12e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MYC—peripheral nervous system neoplasm	3.12e-05	0.000197	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.09e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.09e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.08e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.08e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.08e-05	0.000195	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—NRAS—peripheral nervous system neoplasm	3.07e-05	0.000194	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.06e-05	0.000193	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.06e-05	0.000193	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—peripheral nervous system neoplasm	3.04e-05	0.000192	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.03e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.02e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.01e-05	0.000191	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.01e-05	0.000191	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—PTPN11—peripheral nervous system neoplasm	3e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—PTPN11—peripheral nervous system neoplasm	3e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3e-05	0.00019	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—PTPN11—peripheral nervous system neoplasm	2.98e-05	0.000188	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.94e-05	0.000186	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.94e-05	0.000186	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.9e-05	0.000184	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.88e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.88e-05	0.000182	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—peripheral nervous system neoplasm	2.85e-05	0.000181	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.83e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.83e-05	0.000179	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.81e-05	0.000178	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.81e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.8e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.8e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.79e-05	0.000177	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.78e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.78e-05	0.000176	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.77e-05	0.000175	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.75e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.75e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTPN11—peripheral nervous system neoplasm	2.75e-05	0.000174	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.73e-05	0.000173	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.72e-05	0.000172	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—HRAS—peripheral nervous system neoplasm	2.69e-05	0.00017	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.67e-05	0.000169	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.66e-05	0.000168	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.66e-05	0.000168	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.64e-05	0.000167	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—peripheral nervous system neoplasm	2.61e-05	0.000165	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.6e-05	0.000164	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	2.59e-05	0.000164	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—ERBB2—peripheral nervous system neoplasm	2.57e-05	0.000163	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.57e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.56e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.56e-05	0.000162	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.56e-05	0.000162	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.53e-05	0.00016	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.5e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.5e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.5e-05	0.000158	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—HRAS—peripheral nervous system neoplasm	2.48e-05	0.000157	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.46e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.46e-05	0.000155	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000155	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.43e-05	0.000154	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.41e-05	0.000152	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.39e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.39e-05	0.000151	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.37e-05	0.00015	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ERBB2—peripheral nervous system neoplasm	2.37e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ERBB2—peripheral nervous system neoplasm	2.37e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—AKT1—peripheral nervous system neoplasm	2.37e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.36e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.36e-05	0.00015	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ERBB2—peripheral nervous system neoplasm	2.35e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.35e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.35e-05	0.000149	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.34e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.34e-05	0.000148	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.34e-05	0.000148	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.3e-05	0.000146	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.3e-05	0.000145	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000144	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.26e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.26e-05	0.000143	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—HRAS—peripheral nervous system neoplasm	2.25e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000142	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.21e-05	0.00014	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.2e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—peripheral nervous system neoplasm	2.19e-05	0.000139	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.18e-05	0.000138	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ERBB2—peripheral nervous system neoplasm	2.17e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—peripheral nervous system neoplasm	2.16e-05	0.000137	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.14e-05	0.000135	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.13e-05	0.000134	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.12e-05	0.000134	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.11e-05	0.000133	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.1e-05	0.000133	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.08e-05	0.000132	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.02e-05	0.000127	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2e-05	0.000126	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000126	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.98e-05	0.000125	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.96e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.96e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.96e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NRAS—peripheral nervous system neoplasm	1.96e-05	0.000124	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.95e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.94e-05	0.000123	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.92e-05	0.000122	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.89e-05	0.00012	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.87e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.87e-05	0.000119	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.83e-05	0.000116	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.82e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.82e-05	0.000115	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—NRAS—peripheral nervous system neoplasm	1.81e-05	0.000114	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—NRAS—peripheral nervous system neoplasm	1.81e-05	0.000114	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.79e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NRAS—peripheral nervous system neoplasm	1.79e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000113	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.000112	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.76e-05	0.000111	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.75e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.74e-05	0.00011	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.71e-05	0.000108	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.71e-05	0.000108	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.71e-05	0.000108	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—peripheral nervous system neoplasm	1.68e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—peripheral nervous system neoplasm	1.68e-05	0.000106	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000106	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.66e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.65e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.65e-05	0.000105	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—NRAS—peripheral nervous system neoplasm	1.65e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.65e-05	0.000104	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.61e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.57e-05	9.91e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—peripheral nervous system neoplasm	1.54e-05	9.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.53e-05	9.7e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.53e-05	9.7e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.52e-05	9.63e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.52e-05	9.62e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.51e-05	9.57e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.51e-05	9.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.51e-05	9.55e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.48e-05	9.34e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.47e-05	9.33e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.47e-05	9.31e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.44e-05	9.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.43e-05	9.06e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HRAS—peripheral nervous system neoplasm	1.43e-05	9.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.39e-05	8.81e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.38e-05	8.75e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.38e-05	8.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.38e-05	8.73e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.38e-05	8.7e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.35e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—peripheral nervous system neoplasm	1.34e-05	8.51e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—HRAS—peripheral nervous system neoplasm	1.32e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—HRAS—peripheral nervous system neoplasm	1.32e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HRAS—peripheral nervous system neoplasm	1.31e-05	8.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.3e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.29e-05	8.15e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.27e-05	8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.26e-05	8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—peripheral nervous system neoplasm	1.26e-05	7.99e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.25e-05	7.93e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.24e-05	7.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.22e-05	7.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—HRAS—peripheral nervous system neoplasm	1.21e-05	7.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.18e-05	7.45e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—peripheral nervous system neoplasm	1.17e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—peripheral nervous system neoplasm	1.17e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.16e-05	7.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—peripheral nervous system neoplasm	1.16e-05	7.31e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.13e-05	7.15e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.08e-05	6.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.08e-05	6.82e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—peripheral nervous system neoplasm	1.07e-05	6.75e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.06e-05	6.69e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	6.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.01e-05	6.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	9.95e-06	6.29e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.84e-06	6.23e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—peripheral nervous system neoplasm	9.77e-06	6.18e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.68e-06	6.12e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.54e-06	6.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.25e-06	5.85e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.93e-06	5.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.85e-06	5.6e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.69e-06	5.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.46e-06	5.35e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.17e-06	5.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.47e-06	4.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.69e-06	1.7e-05	CbGpPWpGaD
